Literature DB >> 6093926

GABA receptors mediate cerebral vasodilation in the unanesthetized goat.

E Alborch, G Torregrosa, J C Terrasa, C Estrada.   

Abstract

The effects of gamma-aminobutyric acid (GABA) and muscimol upon cerebral blood flow were evaluated in the unanesthetized goat. Cerebral blood flow was continuously measured by means of an electromagnetic flow probe chronically implanted on the internal maxillary artery after occlusion and thrombosis of the distal extracerebral vessels. Administration of GABA (1-100 micrograms) directly into the cerebral circulation produced dose-dependent increases in cerebral blood flow, without accompanying systemic effects. Muscimol mimicked the effects of GABA at doses 10 times lower. Administration of picrotoxin (1-3 mg) into the internal maxillary artery did not significantly change cerebral blood flow, but inhibited in a dose-dependent manner the vasodilation induced by GABA. Selective blockade of beta-adrenergic or muscarinic cholinergic receptors by propranolol or atropine, respectively, did not modify the cerebrovascular response to the GABAergic agonists. These results indicate that GABA increases total cerebral blood flow, acting on specific receptor sites in the cerebral blood vessels. The absence of influence of picrotoxin on resting cerebral blood flow suggests that the GABAergic receptors are not tonically activated under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093926     DOI: 10.1016/0006-8993(84)90685-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Failure of ischemic neuroprotection by potentiators of gamma-aminobutyric acid.

Authors:  Ken Madden; Wayne Clark; Nicola Lessov
Journal:  Clin Med Res       Date:  2003-04

2.  Modulation of brain function by targeted delivery of GABA through the disrupted blood-brain barrier.

Authors:  Nick Todd; Yongzhi Zhang; Chanikarn Power; Lino Becerra; David Borsook; Margaret Livingstone; Nathan McDannold
Journal:  Neuroimage       Date:  2019-01-16       Impact factor: 6.556

3.  Study of neurovascular coupling by modulating neuronal activity with GABA.

Authors:  Harsha Radhakrishnan; Weicheng Wu; David Boas; Maria Angela Franceschini
Journal:  Brain Res       Date:  2010-12-08       Impact factor: 3.252

Review 4.  Sleep, brain vascular health and ageing.

Authors:  Arehally M Mahalakshmi; Bipul Ray; Sunanda Tuladhar; Abid Bhat; Muhammed Bishir; Srinivasa Rao Bolla; Jian Yang; Musthafa Mohamed Essa; Saravana Babu Chidambaram; Gilles J Guillemin; Meena Kishore Sakharkar
Journal:  Geroscience       Date:  2020-08-03       Impact factor: 7.713

5.  Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation.

Authors:  W S Lee; V Limmroth; C Ayata; F M Cutrer; C Waeber; X Yu; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

6.  High-field MRS study of GABA+ in patients with migraine: response to levetiracetam treatment.

Authors:  Qiang Li; Chunfu Chen; Tao Gong
Journal:  Neuroreport       Date:  2018-08-15       Impact factor: 1.837

7.  Accumulation of 3-aminopropylphosphonate in the ex vivo brain observed by phosphorus-31 nuclear magnetic resonance.

Authors:  David Shaul; Benjamin Grieb; Naama Lev-Cohain; Jacob Sosna; J Moshe Gomori; Rachel Katz-Brull
Journal:  NMR Biomed       Date:  2022-03-13       Impact factor: 4.478

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.